Oct 2026· npj Drug Discovery· Vol 3· 0 citations· 61 references
Medicine
TL;DR
PepOpt is an interpretable machine learning framework that unifies molecule-based and sequence-based peptide representations in linear models and exploits dynamic programming to efficiently explore ultralarge peptide spaces, accelerating the rational design of novel peptide therapeutics.
Abstract
In modern peptide drug discovery, the incorporation of noncanonical amino acids (ncAAs) has become a powerful strategy to improve potency and key developability properties, including stability, solubility, and oral bioavailability. This shift has expanded peptide chemical diversity and design spaces well beyond natural residues, creating fundamental challenges for predictive methods (e.g., quantitative structure-activity relationship modeling) used in lead optimization: limited transferability from natural residues to novel ncAAs, limited interpretability, and poor scalability to ultralarge peptide spaces (>1050). We present PepOpt, an interpretable machine learning framework that unifies molecule-based and sequence-based peptide representations in linear models and exploits dynamic programming to efficiently explore ultralarge peptide spaces. PepOpt achieves high predictive accuracy and interpretability, supports training and inference across diverse ncAAs, including ncAAs absent from the training set whose constituent substructures are represented in the training data. Its linear structure decomposes predictions into residue-specific contributions, enabling systematic optimization without exhaustive sequence enumeration. Notably, PepOpt is inherently capable of multi-parameter optimization without specialized modifications. Together, these capabilities position PepOpt as a valuable platform for prediction, interpretation, ideation, and rapid exploration in ncAA-rich ultralarge peptide chemical spaces, accelerating the rational design of novel peptide therapeutics.
HelixDTA is introduced, a deep learning framework featuring a parallel dual-branch architecture that independently learns representations from two distinct but complementary modalities: sequence context and complete target structures that demonstrates significant potential to empower precision drug design and accelerat...
Shang Lou, Xu-Hua Li, Yu-Jie Peng et al.· Journal of Chemical Informat...· 0 citations
ABSTRACT Peptides combine the favorable pharmacokinetics of small molecules with the high specificity of biologics, making them promising therapeutics. Incorporating non‐canonical amino acids (ncAAs) further enhances drug‐like properties, yet modeling remains challenging due to chemically modified residues and combinat...
Chen-Cheng Xu, Le-Song Wei, Jian-Min Wang et al.· Advancement of science· 1 citation
Accurate identification of protein−nucleic acid binding sites is essential for elucidating molecular mechanisms and for enabling structure-based drug discovery. Existing computational approaches struggle to jointly model sequence, structure, and domain knowledge, which limits both predictive accuracy and interpretabi...
Wen-Yu Xi, Ru-Heng Wang, Xiu-Cai Ye et al.· ACS Synthetic Biology· 0 citations
Peptides occupy a valuable niche between small molecules and biologics, but the clinical translation of de novo peptide designs requires rigorous scoring to simultaneously optimise target binding affinity alongside multiple developability traits, including stability, membrane permeability, aggregation propensity, and n...
Quentin Trolliet, A. Abrudan, Aryan Bhasin et al.· bioRxiv· 0 citations
Enzymes are efficient and selective biocatalysts, yet obtaining enzymes with desired properties remains challenging due to vast sequence spaces, incomplete functional annotation, limited structural information, and costly experimental screening. Machine learning (ML) offers a powerful complement to address these limi...
A priori estimation of molecular properties has long been a topic of immense interest to the pharmaceutical sciences for molecular design. While neural network-based models have achieved high predictive accuracy, they have limited utility in molecular design, particularly in small and out-of-distribution data regimes...
Christian Natajaya, L. Attia, Jackson W. Burns et al.· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.